- Home
- HOWL vs MDCX Comparison
HOWL vs MDCX Comparison
Compare HOWL & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HOWL | MDCX |
|---|---|---|
| Founded | 2017 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.5M | 53.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | HOWL | MDCX |
|---|---|---|
| Price | $1.08 | $1.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $7.00 | ★ $23.50 |
| AVG Volume (30 Days) | ★ 517.1K | 352.3K |
| Earning Date | 11-04-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.60 | $1.68 |
| 52 Week High | $2.38 | $8.94 |
Technical Indicators
Market Signals| Indicator | HOWL | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 52.22 | 45.36 |
| Support Level | $0.96 | $1.68 |
| Resistance Level | $1.03 | $2.25 |
| Average True Range (ATR) | 0.09 | 0.19 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 96.55 | 50.59 |
Price Performance
Historical ComparisonAbout HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.